Wellis brings more than 20 years experience in the life sciences and over ten years experience in product commercialisation in genomics
David Wellis has served GenVault as its senior vice president of marketing and sales since December 2004 and its vice president of business development and marketing since April 2002.
"David combines strong leadership and communication skills with the technical depth and market vision required to grow and establish GenVault as the leader in biosample management," said James Blair of Domain Associates and GenVault's chairman.
Prior to GenVault, Dr Wellis served as the vice president of functional genomics of Axon Instruments , which achieved a successful IPO in 2000.
Wellis holds a BS in biological sciences from UC Irvine, an MS and PhD in cell biology from Emory University and received postdoctoral training at Tufts University Medical School and UC Berkeley.
Additionally, he received business training at the Leavey School of Business, Santa Clara University and UC Berkeley.
GenVault provides DNA sample accessibility for genomic discovery, medicine and identification.
GenVault serves customers across medical centres, academic institutions, pharmaceutical companies, and law enforcement agencies.
As a scalable and reliable alternative to traditional freezers and DNA purification systems, GenVault's dry-state platform enables the extraction, preservation, recovery and distribution of DNA at room temperature.
Future systems will also accommodate proteins and RNA to provide a comprehensive solution.
From its GenPlate to its Dynamic Archive solution, GenVault says it is continuously developing and refining best practices for DNA sample management.
